Puestow Procedure for the Management of Pediatric Chronic Pancreatitis

Research output: Contribution to journalArticle

Abstract

Objective Recurrent pancreatitis significantly impacts childhood development and quality of life. Our goal was to evaluate the efficacy of the Puestow procedure. Materials and Methods After obtaining the Institutional Review Board approval, we reviewed the charts of all patients who underwent lateral pancreaticojejunostomy from January 1999 to January 2014. Statistical analysis was performed using paired Student's t -test and Fisher's exact test as appropriate. Results During the 15-year study period, 13 patients underwent a lateral pancreaticojejunostomy for chronic pancreatitis. The most common causes of pancreatitis were hereditary (n = 5) or obstructive (n = 5); pancreas divisum (n = 2), one iatrogenic stricture, one idiopathic stricture, and one unresectable pancreatic head mass); two patients had idiopathic disease, and one case was drug-induced. Six patients had failed management with endoscopic retrograde cholangiopancreatography and pancreatic duct stenting. Preoperatively, the median body mass index (BMI) percentile-for-age was 61.0% (range 11.0-99.0%). Median age at operation was 12.8 years (range 7.7-16.7). There were no deaths, four patients developed postoperative ileus, and one patient developed an intra-abdominal abscess, which resolved with antibiotics. Median postoperative length of stay was 7 days (range 5-15). Two patients were lost to follow-up; median follow-up for the remaining 12 patients was 35.5 months (range 4.9-131.2). Four patients were readmitted within 90 days: three due to abdominal pain which were not recurrences of pancreatitis, and one due to complications of chemotherapy. Postoperatively, there was no change in the average BMI percentile-for-age (p = 0.64). Seven patients reported resolution or significant improvement in their abdominal pain symptoms at the time of last follow-up. Patients with obstructive causes of pancreatitis were not more likely to experience relief than those with nonobstructive causes (42.9 vs. 80.0%, p = 0.29). Conclusion In our experience, lateral pancreaticojejunostomy results in durable improvement or resolution of abdominal pain symptoms in nearly 60% of patients with chronic pancreatitis regardless of etiology.

Original languageEnglish (US)
Pages (from-to)153-158
Number of pages6
JournalEuropean Journal of Pediatric Surgery
Volume29
Issue number2
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Chronic Pancreatitis
Pediatrics
Pancreaticojejunostomy
Pancreatitis
Abdominal Pain
Pathologic Constriction
Body Mass Index
Abdominal Abscess
Ileus
Endoscopic Retrograde Cholangiopancreatography
Pancreatic Ducts
Research Ethics Committees
Lost to Follow-Up
Pancreas
Length of Stay
Quality of Life
Students
Anti-Bacterial Agents

Keywords

  • chronic pancreatitis
  • lateral pancreaticojejunostomy
  • pediatrics
  • Puestow

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Puestow Procedure for the Management of Pediatric Chronic Pancreatitis. / Hodgman, Erica; Megison, Stephen M; Murphy, Joseph T.

In: European Journal of Pediatric Surgery, Vol. 29, No. 2, 01.01.2019, p. 153-158.

Research output: Contribution to journalArticle

@article{cfda5f6501134e1fa80ecd5a3f238c74,
title = "Puestow Procedure for the Management of Pediatric Chronic Pancreatitis",
abstract = "Objective Recurrent pancreatitis significantly impacts childhood development and quality of life. Our goal was to evaluate the efficacy of the Puestow procedure. Materials and Methods After obtaining the Institutional Review Board approval, we reviewed the charts of all patients who underwent lateral pancreaticojejunostomy from January 1999 to January 2014. Statistical analysis was performed using paired Student's t -test and Fisher's exact test as appropriate. Results During the 15-year study period, 13 patients underwent a lateral pancreaticojejunostomy for chronic pancreatitis. The most common causes of pancreatitis were hereditary (n = 5) or obstructive (n = 5); pancreas divisum (n = 2), one iatrogenic stricture, one idiopathic stricture, and one unresectable pancreatic head mass); two patients had idiopathic disease, and one case was drug-induced. Six patients had failed management with endoscopic retrograde cholangiopancreatography and pancreatic duct stenting. Preoperatively, the median body mass index (BMI) percentile-for-age was 61.0{\%} (range 11.0-99.0{\%}). Median age at operation was 12.8 years (range 7.7-16.7). There were no deaths, four patients developed postoperative ileus, and one patient developed an intra-abdominal abscess, which resolved with antibiotics. Median postoperative length of stay was 7 days (range 5-15). Two patients were lost to follow-up; median follow-up for the remaining 12 patients was 35.5 months (range 4.9-131.2). Four patients were readmitted within 90 days: three due to abdominal pain which were not recurrences of pancreatitis, and one due to complications of chemotherapy. Postoperatively, there was no change in the average BMI percentile-for-age (p = 0.64). Seven patients reported resolution or significant improvement in their abdominal pain symptoms at the time of last follow-up. Patients with obstructive causes of pancreatitis were not more likely to experience relief than those with nonobstructive causes (42.9 vs. 80.0{\%}, p = 0.29). Conclusion In our experience, lateral pancreaticojejunostomy results in durable improvement or resolution of abdominal pain symptoms in nearly 60{\%} of patients with chronic pancreatitis regardless of etiology.",
keywords = "chronic pancreatitis, lateral pancreaticojejunostomy, pediatrics, Puestow",
author = "Erica Hodgman and Megison, {Stephen M} and Murphy, {Joseph T}",
year = "2019",
month = "1",
day = "1",
doi = "10.1055/s-0037-1608938",
language = "English (US)",
volume = "29",
pages = "153--158",
journal = "European Journal of Pediatric Surgery",
issn = "0939-7248",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Puestow Procedure for the Management of Pediatric Chronic Pancreatitis

AU - Hodgman, Erica

AU - Megison, Stephen M

AU - Murphy, Joseph T

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective Recurrent pancreatitis significantly impacts childhood development and quality of life. Our goal was to evaluate the efficacy of the Puestow procedure. Materials and Methods After obtaining the Institutional Review Board approval, we reviewed the charts of all patients who underwent lateral pancreaticojejunostomy from January 1999 to January 2014. Statistical analysis was performed using paired Student's t -test and Fisher's exact test as appropriate. Results During the 15-year study period, 13 patients underwent a lateral pancreaticojejunostomy for chronic pancreatitis. The most common causes of pancreatitis were hereditary (n = 5) or obstructive (n = 5); pancreas divisum (n = 2), one iatrogenic stricture, one idiopathic stricture, and one unresectable pancreatic head mass); two patients had idiopathic disease, and one case was drug-induced. Six patients had failed management with endoscopic retrograde cholangiopancreatography and pancreatic duct stenting. Preoperatively, the median body mass index (BMI) percentile-for-age was 61.0% (range 11.0-99.0%). Median age at operation was 12.8 years (range 7.7-16.7). There were no deaths, four patients developed postoperative ileus, and one patient developed an intra-abdominal abscess, which resolved with antibiotics. Median postoperative length of stay was 7 days (range 5-15). Two patients were lost to follow-up; median follow-up for the remaining 12 patients was 35.5 months (range 4.9-131.2). Four patients were readmitted within 90 days: three due to abdominal pain which were not recurrences of pancreatitis, and one due to complications of chemotherapy. Postoperatively, there was no change in the average BMI percentile-for-age (p = 0.64). Seven patients reported resolution or significant improvement in their abdominal pain symptoms at the time of last follow-up. Patients with obstructive causes of pancreatitis were not more likely to experience relief than those with nonobstructive causes (42.9 vs. 80.0%, p = 0.29). Conclusion In our experience, lateral pancreaticojejunostomy results in durable improvement or resolution of abdominal pain symptoms in nearly 60% of patients with chronic pancreatitis regardless of etiology.

AB - Objective Recurrent pancreatitis significantly impacts childhood development and quality of life. Our goal was to evaluate the efficacy of the Puestow procedure. Materials and Methods After obtaining the Institutional Review Board approval, we reviewed the charts of all patients who underwent lateral pancreaticojejunostomy from January 1999 to January 2014. Statistical analysis was performed using paired Student's t -test and Fisher's exact test as appropriate. Results During the 15-year study period, 13 patients underwent a lateral pancreaticojejunostomy for chronic pancreatitis. The most common causes of pancreatitis were hereditary (n = 5) or obstructive (n = 5); pancreas divisum (n = 2), one iatrogenic stricture, one idiopathic stricture, and one unresectable pancreatic head mass); two patients had idiopathic disease, and one case was drug-induced. Six patients had failed management with endoscopic retrograde cholangiopancreatography and pancreatic duct stenting. Preoperatively, the median body mass index (BMI) percentile-for-age was 61.0% (range 11.0-99.0%). Median age at operation was 12.8 years (range 7.7-16.7). There were no deaths, four patients developed postoperative ileus, and one patient developed an intra-abdominal abscess, which resolved with antibiotics. Median postoperative length of stay was 7 days (range 5-15). Two patients were lost to follow-up; median follow-up for the remaining 12 patients was 35.5 months (range 4.9-131.2). Four patients were readmitted within 90 days: three due to abdominal pain which were not recurrences of pancreatitis, and one due to complications of chemotherapy. Postoperatively, there was no change in the average BMI percentile-for-age (p = 0.64). Seven patients reported resolution or significant improvement in their abdominal pain symptoms at the time of last follow-up. Patients with obstructive causes of pancreatitis were not more likely to experience relief than those with nonobstructive causes (42.9 vs. 80.0%, p = 0.29). Conclusion In our experience, lateral pancreaticojejunostomy results in durable improvement or resolution of abdominal pain symptoms in nearly 60% of patients with chronic pancreatitis regardless of etiology.

KW - chronic pancreatitis

KW - lateral pancreaticojejunostomy

KW - pediatrics

KW - Puestow

UR - http://www.scopus.com/inward/record.url?scp=85062946072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062946072&partnerID=8YFLogxK

U2 - 10.1055/s-0037-1608938

DO - 10.1055/s-0037-1608938

M3 - Article

C2 - 29220851

AN - SCOPUS:85062946072

VL - 29

SP - 153

EP - 158

JO - European Journal of Pediatric Surgery

JF - European Journal of Pediatric Surgery

SN - 0939-7248

IS - 2

ER -